Expression of both Estrogen Receptor-beta 1 (ER-β1) and its co-regulator Steroid Receptor RNA Activator Protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with Estrogen Receptor-alpha (ER-α)-Negative Early Breast Cancer (EBC)

Publication | Closed Access

DOI

Citations

References

2013

Year

Yi Yan, X. Li, Anne Blanchard, V. Bramwell, Kathleen I. Pritchard, Dongsheng Tu, Lois E. Shepherd, Yvonne Myal, Carla Penner, Peter H. Watson,

Annals of Oncology

Endocrine OncologyBreast OncologyOncologyEstrogen Receptor-alphaMedicineHormonal ReceptorTamoxifen TherapyEstrogen Receptor-beta 1Cancer Cell BiologyBreast CancerAromataseCell BiologySystems BiologyCancer BiologyRadiation OncologyMammary Gland DevelopmentCancer ResearchEndocrine-related Cancer